Prodia Diagnostic Line is trading 4.17% up at IDR 250, rebounding from the IDR 240 close on August 26, 2026, with no confirmed catalyst identified.
- No reliable company-specific announcement for August 28, 2026 was identified, and supplied broader market context was largely flat.
- Recent coverage points to weaker first-half performance, including sharply lower revenue and a net loss.
- Longer-term plans target new products and double-digit growth; the latest indexed market page was updated August 27, 2026.